Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-14

Clinical Trial Update: Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the efficacy and safety of MK-1167 in participants with Alzheimer's disease dementia who are taking stable donepezil; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-1167 (MK-1167)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-10-14